BR9202771A - Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera - Google Patents

Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera

Info

Publication number: BR9202771A
Authority: BR; Brazil
Prior art keywords: blood; microsphere; compounds; introduce; compound
Prior art date: 1991-07-23

Application number

BR929202771A

Other languages

English (en)

Inventor

Susan Mancini Cady

William David Steber

Philip Wayne Hayes

Mary Ehlers Doscher

Kurt Allen Schwinghammer

Original Assignee

American Cyanamid Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-07-23

Filing date

1992-07-20

Publication date

1993-03-23

1992-07-20 Application filed by American Cyanamid Co filed Critical American Cyanamid Co

1993-03-23 Publication of BR9202771A publication Critical patent/BR9202771A/pt

Links

150000001875 compounds Chemical class 0.000 title abstract 5
239000000203 mixture Substances 0.000 title abstract 5
241001465754 Metazoa Species 0.000 title abstract 3
210000004369 blood Anatomy 0.000 title abstract 3
239000004005 microsphere Substances 0.000 title abstract 3
239000008280 blood Substances 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
239000002131 composite material Substances 0.000 title 1
YNFMRVVYUVPIAN-UHFFFAOYSA-N nemadectin alpha Natural products C1C(O)C(C)C(C(C)=CC(C)C)OC11OC(CC=C(C)CC(C)C=CC=C2C3(C(C(=O)O4)C=C(C)C(O)C3OC2)O)CC4C1 YNFMRVVYUVPIAN-UHFFFAOYSA-N 0.000 abstract 2
241000238421 Arthropoda Species 0.000 abstract 1
241000244206 Nematoda Species 0.000 abstract 1
239000004480 active ingredient Substances 0.000 abstract 1
239000003963 antioxidant agent Substances 0.000 abstract 1
230000003078 antioxidant effect Effects 0.000 abstract 1
RRZXIRBKKLTSOM-XPNPUAGNSA-N avermectin B1a Chemical class C1=C[C@H](C)[C@@H]([C@@H](C)CC)O[C@]11O[C@H](C\C=C(C)\[C@@H](O[C@@H]2O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C2)[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 RRZXIRBKKLTSOM-XPNPUAGNSA-N 0.000 abstract 1
235000014113 dietary fatty acids Nutrition 0.000 abstract 1
229930195729 fatty acid Natural products 0.000 abstract 1
239000000194 fatty acid Substances 0.000 abstract 1
150000004665 fatty acids Chemical class 0.000 abstract 1
244000000013 helminth Species 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
FXWHFKOXMBTCMP-WMEDONTMSA-N milbemycin Chemical class COC1C2OCC3=C/C=C/C(C)CC(=CCC4CC(CC5(O4)OC(C)C(C)C(OC(=O)C(C)CC(C)C)C5O)OC(=O)C(C=C1C)C23O)C FXWHFKOXMBTCMP-WMEDONTMSA-N 0.000 abstract 1
YNFMRVVYUVPIAN-AQUURSMBSA-N nemadectin Chemical compound C1[C@H](O)[C@H](C)[C@@H](C(/C)=C/C(C)C)O[C@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YNFMRVVYUVPIAN-AQUURSMBSA-N 0.000 abstract 1
238000007911 parenteral administration Methods 0.000 abstract 1
230000002265 prevention Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Chemical Kinetics & Catalysis (AREA)
Tropical Medicine & Parasitology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BR929202771A 1991-07-23 1992-07-20 Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera BR9202771A (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US73443091A	1991-07-23	1991-07-23

Publications (1)

Publication Number	Publication Date
BR9202771A true BR9202771A (pt)	1993-03-23

Family

ID=24951666

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR929202771A BR9202771A (pt)	1991-07-23	1992-07-20	Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera

Country Status (21)

Country	Link
US (1)	US6340671B1 (pt)
EP (1)	EP0525307B1 (pt)
JP (1)	JP3470904B2 (pt)
KR (1)	KR100235550B1 (pt)
CN (1)	CN1046852C (pt)
AT (1)	ATE134873T1 (pt)
AU (1)	AU651229B2 (pt)
BR (1)	BR9202771A (pt)
CA (1)	CA2074348C (pt)
DE (1)	DE69208765T2 (pt)
DK (1)	DK0525307T3 (pt)
ES (1)	ES2086022T3 (pt)
GR (1)	GR3019234T3 (pt)
HK (1)	HK1000005A1 (pt)
HU (1)	HU220595B1 (pt)
IE (1)	IE74401B1 (pt)
IL (1)	IL102567A (pt)
MX (1)	MX9204135A (pt)
NZ (1)	NZ243619A (pt)
TW (1)	TW201696B (pt)
ZA (1)	ZA925522B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5733566A (en) *	1990-05-15	1998-03-31	Alkermes Controlled Therapeutics Inc. Ii	Controlled release of antiparasitic agents in animals
US5643595A (en) *	1992-11-24	1997-07-01	Alkermes Controlled Therapeutics Inc. Ii	Growth promoters for animals
DE4308282C2 (de) *	1993-03-16	1994-12-22	Beiersdorf Ag	Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices
DE19613972A1 (de) *	1996-04-09	1997-10-16	Bayer Ag	Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de) *	1996-09-18	1998-03-19	Bayer Ag	Injektionsformulierungen von Avermectinen und Milbemycinen
US8663692B1 (en) *	1999-05-07	2014-03-04	Pharmasol Gmbh	Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
BR0010354A (pt) *	1999-05-07	2002-03-05	Pharmasol Gmbh	Partìculas de lipìdeo à base em misturas de lipìdeos lìquidos e sólidos e método para a sua produção
EP1197207B1 (en) *	2000-10-10	2008-04-23	Wyeth Holdings Corporation	Stable compositions for parenteral administration
FR2852843B1 (fr)	2003-03-24	2008-05-23	Karim Ioualalen	Systeme galenique permettant le masquage du gout
NZ534939A (en) *	2004-08-26	2007-04-27	Bomac Research Ltd	Injectable formulation comprising an anthelmintic compound with complexing compound for improved solubility
BR112012008185A2 (pt)	2009-10-07	2016-08-16	Wyeth Llc	composições que compreendem adjuvante, macrolídeo e antígeno proteináceo, e métodos para uso dessas composições
ITUB20153652A1 (it)	2015-09-16	2017-03-16	Fatro Spa	Microsfere contenenti lattoni macrociclici antielminitici
WO2018189314A1 (en)	2017-04-13	2018-10-18	Ceva Sante Animale	Composition for treating worms infestations
KR20220013540A (ko)	2019-02-21	2022-02-04	크로마덱스 아이엔씨.	니코틴아미드 리보사이드, 니코틴산 리보사이드, 환원 니코티닐 리보사이드 화합물, 및 니코티닐 리보사이드 화합물 유도체의 제형에서의 용도
WO2020225143A1 (en)	2019-05-03	2020-11-12	Intervet International B.V.	Injectable pharmaceutical compositions and uses thereof
WO2021233967A1 (en)	2020-05-20	2021-11-25	Intervet International B.V.	Injectable pharmaceutical compositions and uses thereof
WO2022263505A1 (en) *	2021-06-16	2022-12-22	Société des Produits Nestlé S.A.	Methods of solid phase wax coating of an active ingredient
WO2024003291A1 (en)	2022-06-30	2024-01-04	Virbac	Deslorelin use in chemical castration of a non-human mammal related to pk/pd interaction
WO2025190964A1 (en)	2024-03-12	2025-09-18	Virbac	Parenteral modoflaner for the control of ectoparasites
WO2026024600A1 (en)	2024-07-22	2026-01-29	Zoetis Services Llc	Isoxazoline and macrocyclic lactone microspheres

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3659022A (en) *	1967-11-13	1972-04-25	Upjohn Co	Methods of preventing impregnation
US4144352A (en) *	1977-12-19	1979-03-13	Merck & Co., Inc.	Milbemycin compounds as anthelmintic agents
US5106994A (en) *	1984-06-05	1992-04-21	American Cyanamid Company	Agents and method of production thereof
US5169956A (en) *	1984-06-05	1992-12-08	American Cyanamid Company	Macrolide antibiotic compounds
ATE74009T1 (de) *	1986-08-11	1992-04-15	American Cyanamid Co	Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
GB8803836D0 (en) *	1988-02-18	1988-03-16	Glaxo Group Ltd	Compositions
DE69007515T2 (de) *	1989-02-28	1994-11-03	American Cyanamid Co	Bolus mit lang andauernder Wirkstoffabgabe, wirksam bei der Prophylaxe, Behandlung oder Bekämpfung des Befalls bei Wiederkäuern durch Fadenwürmer, Milben und Endo- und Ektoparasiten.
US5213810A (en) *	1990-03-30	1993-05-25	American Cyanamid Company	Stable compositions for parenteral administration and method of making same
US5192546A (en) *	1991-01-15	1993-03-09	Mycogen Corporation	Synergistic pesticidal compositions
US5346698A (en) *	1991-01-15	1994-09-13	Mycogen Corporation	Synergistic pesticidal compositions
US5185108A (en) *	1991-07-10	1993-02-09	The B. F. Goodrich Company	Method for producing wax microspheres
JP4654917B2 (ja)	2006-01-12	2011-03-23	日産自動車株式会社	車体後部構造

1992
- 1992-04-29 EP EP92107277A patent/EP0525307B1/en not_active Expired - Lifetime
- 1992-04-29 AT AT92107277T patent/ATE134873T1/de active
- 1992-04-29 DK DK92107277.3T patent/DK0525307T3/da active
- 1992-04-29 DE DE69208765T patent/DE69208765T2/de not_active Expired - Lifetime
- 1992-04-29 ES ES92107277T patent/ES2086022T3/es not_active Expired - Lifetime
- 1992-05-16 TW TW081103831A patent/TW201696B/zh not_active IP Right Cessation
- 1992-06-30 CN CN92105395A patent/CN1046852C/zh not_active Expired - Lifetime
- 1992-07-15 MX MX9204135A patent/MX9204135A/es unknown
- 1992-07-20 JP JP21325992A patent/JP3470904B2/ja not_active Expired - Lifetime
- 1992-07-20 BR BR929202771A patent/BR9202771A/pt not_active Application Discontinuation
- 1992-07-20 NZ NZ243619A patent/NZ243619A/en unknown
- 1992-07-21 IL IL10256792A patent/IL102567A/en not_active IP Right Cessation
- 1992-07-21 CA CA002074348A patent/CA2074348C/en not_active Expired - Lifetime
- 1992-07-22 ZA ZA925522A patent/ZA925522B/xx unknown
- 1992-07-22 KR KR1019920013077A patent/KR100235550B1/ko not_active Expired - Lifetime
- 1992-07-22 AU AU20472/92A patent/AU651229B2/en not_active Expired
- 1992-07-22 HU HU9202404A patent/HU220595B1/hu unknown
- 1992-07-22 IE IE922373A patent/IE74401B1/en not_active IP Right Cessation
1994
- 1994-06-22 US US08/263,574 patent/US6340671B1/en not_active Expired - Lifetime
1996
- 1996-03-07 GR GR950402159T patent/GR3019234T3/el unknown
1997
- 1997-07-09 HK HK97101523A patent/HK1000005A1/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
MX9204135A (es)	1993-01-01
ATE134873T1 (de)	1996-03-15
AU2047292A (en)	1993-01-28
EP0525307B1 (en)	1996-03-06
KR930001904A (ko)	1993-02-22
JPH05194211A (ja)	1993-08-03
CA2074348A1 (en)	1993-01-24
IL102567A (en)	1996-10-31
HUT62454A (en)	1993-05-28
ZA925522B (en)	1993-04-28
CN1046852C (zh)	1999-12-01
IL102567A0 (en)	1993-01-14
IE922373A1 (en)	1993-01-27
CN1068735A (zh)	1993-02-10
NZ243619A (en)	1994-12-22
HK1000005A1 (en)	1997-10-03
US6340671B1 (en)	2002-01-22
IE74401B1 (en)	1997-07-30
ES2086022T3 (es)	1996-06-16
TW201696B (pt)	1993-03-11
DK0525307T3 (da)	1996-04-01
AU651229B2 (en)	1994-07-14
DE69208765T2 (de)	1996-09-26
HU220595B1 (hu)	2002-03-28
HU9202404D0 (en)	1992-10-28
JP3470904B2 (ja)	2003-11-25
KR100235550B1 (ko)	1999-12-15
DE69208765D1 (de)	1996-04-11
GR3019234T3 (en)	1996-06-30
EP0525307A1 (en)	1993-02-03
CA2074348C (en)	2004-02-17

Publication	Publication Date	Title
BR9202771A (pt)	1993-03-23	Composicao em microesfera e processos para proteger ou tratar animais de sangue quente,para introduzir e manter niveis no sangue de um composto e para preparar composicoes em microesfera
IE44980L (en)	1977-10-06	Pour-on anthelmintic formulations
BRPI0416752A (pt)	2007-02-27	composição farmacêutica, uso de um ou mais compostos, método para a prevenção ou tratamento de distúrbios, compostos, e, processo para a preparação de uma composição farmacêutica
AU781682B2 (en)	2005-06-09	Sustained-release compositions for parenteral administration
CY1108145T1 (el)	2013-03-13	Σταθερες συνθεσεις για παρεντερικη χορηγηση
BRPI0406875A (pt)	2006-01-03	Derivados de monossacarìdeo de avermectina tendo propriedades pesticidas
ES2144154T3 (es)	2000-06-01	Derivados de eritromicina a 9-0-oxima dotados de actividad antibiotica.
DE69331007D1 (de)	2001-11-29	Difluoroavermectin-derivate
BRPI0407271A (pt)	2006-01-31	Composição anti-helmìntica
ES2132283T3 (es)	1999-08-16	Derivados n-heteroaril sustituidos de propanamida utiles en el tratamiento de enfermedades cardiovasculares.
DE3573707D1 (de)	1989-11-23	Anticoccidial compostions
KR950703956A (ko)	1995-11-17	순환 장애 개선제[circulatory disturbance ameliorant]
FR2534809B1 (fr)	1985-06-28	Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci
PT1100463E (pt)	2002-12-31	Novas formulacoes injectaveis contendo ramoplanina
AU2006203347C1 (en)	2009-11-05	Stabilised formulation
DK0505389T3 (da)	1997-09-08	Antiparasitisk præparat til animalsk anvendelse
BR0016427A (pt)	2002-10-29	Método para o tratamento e/ou prevenção da tosse em um animal de sangue quente, uso de um composto, composto, e, composição farmacêutica
JPS5480426A (en)	1979-06-27	Agent for prophylaxis and remedy of mycoplasmosis

Legal Events

Date	Code	Title
1995-06-13	EE	Request for examination
1999-01-26	EG	Technical examination (opinion): publication of technical examination (opinion)
1999-08-17	FC	Decision: refusal
2000-03-08	FC	Decision: refusal